Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V - Gleixner, K. V.; Peter, B.; Blatt, K.; Suppan, V.; Reiter, A.; Radia, D.; Hadzijusufovic, E.; Valent, P. (Haematologica (Roma), 2013)
Keywords: Adult; Aged; Antineoplastic Agents - administration & dosage; Cell Line, Tumor; Drug Synergism; Female; Growth Inhibitors - administration & dosage; Humans; Imidazoles - administration & dosage; Male; Mastocytosis, Systemic - diagnosis; Mastocytosis, Systemic - drug therapy; Mastocytosis, Systemic - genetics; Middle Aged; Proto-Oncogene Proteins c-kit - genetics; Pyridazines - administration & dosage; Staurosporine - administration & dosage; Staurosporine - analogs & derivatives